In summary, metabolic remodeling follows the progression of cardiac hypertrophy in human HCM and is accompanied by reduction of CD36, decreased dependency on FAO for ATP production, higher myocardial glucose uptake, and lower oxygen consumption. Here, CD36 is linked to cardiac hypertrophy.